Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShare-based Compensation (IS)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

IM Cannabis (IMCC) EBIT: 2019-2024

Historic EBIT for IM Cannabis (IMCC) over the last 6 years, with Dec 2024 value amounting to -$7.5 million.

  • IM Cannabis' EBIT fell 331.86% to -$3.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $870,777, marking a year-over-year increase of 103.96%. This contributed to the annual value of -$7.5 million for FY2024, which is 21.16% up from last year.
  • As of FY2024, IM Cannabis' EBIT stood at -$7.5 million, which was up 21.16% from -$9.5 million recorded in FY2023.
  • IM Cannabis' EBIT's 5-year high stood at -$6.2 million during FY2020, with a 5-year trough of -$23.7 million in FY2022.
  • Moreover, its 3-year median value for EBIT was -$9.5 million (2023), whereas its average is -$13.5 million.
  • As far as peak fluctuations go, IM Cannabis' EBIT plummeted by 198.65% in 2021, and later spiked by 59.97% in 2023.
  • IM Cannabis' EBIT (Yearly) stood at -$6.2 million in 2020, then tumbled by 198.65% to -$18.4 million in 2021, then decreased by 28.85% to -$23.7 million in 2022, then soared by 59.97% to -$9.5 million in 2023, then grew by 21.16% to -$7.5 million in 2024.